Deep Track Capital, LP
Deep Track Capital, LP is an investment firm headquartered in Greenwich, Connecticut, specializing in the life sciences industry. Founded in 2020, the firm partners with public and pre-IPO biotechnology companies, providing capital, strategic guidance, and access to networks. The team is led by experienced professionals with backgrounds in healthcare finance and investment. Deep Track Capital employs 19 people and operates with a strong focus on innovation in biotechnology and life sciences, serving institutional investors and company management teams.
Investment Strategy
Deep Track Capital focuses exclusively on the life sciences industry, developing long-term partnerships with management teams of leading public and pre-IPO biotechnology companies. The firm utilizes a fundamentally driven, research-intensive strategy to identify high-potential investments primarily in biotechnology and healthcare sectors. Deep Track Capital invests its time and expertise, often leading transactions and building syndicates, and participates in rounds led by other qualified investors. Its approach centers on generating superior risk-adjusted returns by leveraging industry expertise and expansive networks, targeting companies with strong growth potential and innovative solutions for unmet medical needs.
Top Holdings
Equity Positions (64)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
G GH | GUARDANT HEALTH INC | 7.09% | $221.2M | 4,250,000 | $27.83 | $52.04 | -$10.7M |
I IONS | IONIS PHARMACEUTICALS INC | 6.20% | $193.3M | 4,891,544 | $34.81 | $39.51 | +$55.6M |
P PTGX | PROTAGONIST THERAPEUTICS INC | 5.75% | $179.4M | 3,245,899 | $45.88 | $55.27 | +$34.3M |
D DVAX | DYNAVAX TECHNOLOGIES CORP | 5.66% | $176.5M | 17,791,486 | $11.54 | $9.92 | -$54.3M |
I INSM | INSMED INC | 5.65% | $176.1M | 1,750,000 | $97.10 | $100.64 | +$156.7M |
Options Positions (1)
| Ticker | Security | Action | Type | Notional Value | Contracts | Underlying Price | Premium Paid | Change (Contracts) | Change (Value) |
|---|---|---|---|---|---|---|---|---|---|
S SRPT | SAREPTA THERAPEUTICS INC | New | Put | $7.7M | 4,500 | $17.10 | $17.10 | +4,500 | +$7.7M |
Industry Allocation
Investment Team (2)
| Name | Role | Location | |
|---|---|---|---|
B Brett Erkman | Managing Director | New York, NY , United States | |
 | Principal | Greenwich, CT , United States |